Celldex Therapeutics to Report Fourth Quarter and Fiscal 2012 Financial
Results and Host Corporate 2013 Strategic Outlook Call
Call Scheduled for March 7, 2013 at 8:30 a.m. ET
NEEDHAM, Mass., Feb. 28, 2013 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc.
(Nasdaq:CLDX) will release fourth quarter and year end 2012 financial results
on Thursday, March 7, 2013 before the U.S. financial markets open. Celldex
executives will host a conference call at 8:30 a.m. ET on the same day to
discuss 2012 financial and business results and to provide an update on key
The conference call and presentation will be webcast live over the Internet
and can be accessed by logging on to the Events Calendar under the "News &
Events" section of the Celldex Therapeutics website at
www.celldextherapeutics.com. The call can also be accessed by dialing
888-350-0137 (within the United States) or 970-315-0478 (outside the United
A replay of the call will be available approximately two hours after the live
call concludes through March 21, 2013. To access the replay, dial 855-859-2056
(within the United States) or 404-537-3406 (outside the United States). The
passcode is 13866763. The webcast will also be archived on the Company's
About Celldex Therapeutics, Inc.
Celldex Therapeutics is the first antibody-based combination immunotherapy
company. Celldex has a pipeline of drug candidates in development for the
treatment of cancer and other difficult-to-treat diseases based on its
antibody focused Precision Targeted Immunotherapy (PTI) Platform. The PTI
Platform is a complementary portfolio of monoclonal antibodies,
antibody-targeted therapeutics and immunomodulators used in optimal
combinations to create novel disease-specific drug candidates. For more
information, please visit http://www.celldextherapeutics.com.
CONTACT: Sarah Cavanaugh
Vice President of Investor Relations &
Celldex Therapeutics, Inc.
Press spacebar to pause and continue. Press esc to stop.